TROSPIUM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Trospium Chloride patents expire, and what generic alternatives are available?
Trospium Chloride is a drug marketed by Actavis Labs Fl Inc, Granules, Padagis Us, Upsher Smith Labs, Utopic Pharms, Apotex, Glenmark Pharms Ltd, Heritage Pharms Inc, Invagen Pharms, Macleods Pharms, and Zameer Pharms. and is included in twelve NDAs.
The generic ingredient in TROSPIUM CHLORIDE is trospium chloride. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the trospium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trospium Chloride
A generic version of TROSPIUM CHLORIDE was approved as trospium chloride by GLENMARK PHARMS LTD on August 13th, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TROSPIUM CHLORIDE?
- What are the global sales for TROSPIUM CHLORIDE?
- What is Average Wholesale Price for TROSPIUM CHLORIDE?
Summary for TROSPIUM CHLORIDE
Recent Clinical Trials for TROSPIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| European Group for Research In Schizophrenia | PHASE3 |
| University Medical Center Groningen | PHASE3 |
| University of Texas Southwestern Medical Center | EARLY_PHASE1 |
Pharmacology for TROSPIUM CHLORIDE
| Drug Class | Cholinergic Muscarinic Antagonist |
| Mechanism of Action | Cholinergic Muscarinic Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for TROSPIUM CHLORIDE
Paragraph IV (Patent) Challenges for TROSPIUM CHLORIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| SANCTURA XR | Extended-release Capsules | trospium chloride | 60 mg | 022103 | 1 | 2009-03-02 |
US Patents and Regulatory Information for TROSPIUM CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | TROSPIUM CHLORIDE | trospium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 091289-001 | Oct 12, 2012 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Glenmark Pharms Ltd | TROSPIUM CHLORIDE | trospium chloride | TABLET;ORAL | 091575-001 | Aug 13, 2010 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Upsher Smith Labs | TROSPIUM CHLORIDE | trospium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 091635-001 | Apr 29, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zameer Pharms | TROSPIUM CHLORIDE | trospium chloride | TABLET;ORAL | 215781-001 | Feb 16, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Heritage Pharms Inc | TROSPIUM CHLORIDE | trospium chloride | TABLET;ORAL | 204945-001 | Aug 30, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
